15.04
-0.16
(-1.05%)
At close: January 31 at 4:00:02 PM EST
14.60
-0.44
(-2.93%)
After hours: 7:59:25 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-36,793.47
-25,596.55
4,916.64
-16,809.32
-10,054.81
Investing Cash Flow
1,335.12
5,108.21
-35,072.51
-1,196.29
5,439.21
Financing Cash Flow
94,851.08
25,579.95
4,873.84
20,225.01
33,382.15
End Cash Position
68,377.40
14,694.86
9,603.24
34,885.27
32,665.87
Capital Expenditure
-1,533.48
-2,047.53
-3,359.73
-1,196.29
-547.60
Issuance of Capital Stock
94,645.84
25,515.35
4,803.53
20,174.45
27,343.07
Issuance of Debt
--
--
--
--
318.16
Free Cash Flow
-38,326.94
-27,644.08
1,556.91
-18,005.61
-10,602.41
12/31/2020 - 2/13/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CADL Candel Therapeutics, Inc.
7.07
+1.58%
MESO Mesoblast Limited
20.14
+3.18%
ATRA Atara Biotherapeutics, Inc.
8.88
+4.59%
VRNA Verona Pharma plc
57.30
+0.10%
SRPT Sarepta Therapeutics, Inc.
113.72
-0.64%
EWTX Edgewise Therapeutics, Inc.
28.02
+0.07%
ATYR aTyr Pharma, Inc.
3.8600
+3.21%
CRMD CorMedix Inc.
10.27
-6.38%
AVXL Anavex Life Sciences Corp.
9.27
-3.13%
WVE Wave Life Sciences Ltd.
11.57
-4.06%